AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
HC Wainwright Raises BNGO Price Target to $11.00
ByAinvest
Monday, Aug 18, 2025 2:24 pm ET1min read
HC Wainwright & Co. has maintained a "Buy" rating for Bionano Genomics (BNGO) and raised its price target from $10 to $11, a 10% increase. Analyst Yi Chen anticipates continued growth and performance in line with the new price target. Bionano Genomics is a life sciences instrumentation company focused on genome analysis, and its Saphyr system enables researchers and clinicians to identify new diagnostics and therapeutic targets.
H.C. Wainwright & Co. has raised its price target for Bionano Genomics (BNGO) to $11 from $10, a 10% increase, while maintaining a "Buy" rating on the shares. The analyst, Yi Chen, cited sequential revenue growth in Q2 2025 as the primary reason for the upward revision [1].Bionano Genomics, a life sciences instrumentation company, specializes in genome analysis. Its Saphyr system is designed to help researchers and clinicians identify new diagnostics and therapeutic targets. Despite a 13% decline in total revenue to $6.7 million in Q2 2025 compared to Q2 2024, the company reported a significant increase in non-GAAP gross margin to 52% from 35% a year ago, indicating improved profitability [2].
The company also experienced a 17% year-over-year increase in flow cell sales, reflecting strong demand and utilization among existing customers. Non-GAAP operating expenses were reduced by 53% year-over-year, showcasing effective cost management [2]. For the full year 2025, Bionano Genomics expects revenue to be in the range of $26 million to $30 million, with Q3 revenue guidance of $6.7 million to $7.2 million [2].
Analyst Yi Chen anticipates continued growth and performance in line with the new price target. The company's strategic focus on AI-driven software development and the successful expansion of its VIA software, widely accepted as a gold standard for CNV analysis, are key drivers for future growth [1].
References:
[1] https://www.tipranks.com/news/the-fly/bionano-genomics-price-target-raised-to-11-from-10-at-h-c-wainwright-thefly
[2] https://finance.yahoo.com/news/bionano-genomics-inc-bngo-q2-072343258.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet